In this photo illustration, a silhouette of hands in medical gloves holds a medical syringe and a vial in front of the Pfizer logo of a US pharmaceutical industry company. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) Since the winter surge, cases have plummeted, as have the hospitalization and death rates — relieving the health care system."We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in collaboration with the U.S.
Government," Pfizer’s Chairman and Chief Executive Officer Albert Bourla said. "We look forward to working with the FDA to complete this rolling submission and support their review, with the goal of securing full regulatory.